Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PCC RokitaWAR:PCR +8.26%82 EBITDA Margin % is 10.76% as of Mar. 2026, which is 51% below its 10-year median of 21.93. GuruFocus rates WAR:PCR with a GF Score™ of 82/100 and a GF Value™ of zł66.24 (Fairly Valued). The stock has 8 warning signs investors should review. Among 1,578 Chemicals companies, PCC Rokita ranks better than 66.67% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. PCC Rokita's EBITDA for the
three
months ended in Mar. 2026 was zł47 Mil. PCC Rokita's Revenue for the
three
months ended in Mar. 2026 was zł432 Mil. Therefore, PCC Rokita's EBITDA margin for the quarter that ended in Mar. 2026 was 10.76%.
PCC Rokita (WAR:PCR) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
PCC Rokita EBITDA Margin % Related Terms
PCC Rokita EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for PCC Rokita's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, PCC Rokita's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PCC Rokita EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, PCC Rokita's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where PCC Rokita's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PCC Rokita (WAR:PCR) has a EBITDA Margin % of 10.76% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PCC Rokita and its competitors. This is 51% below median its historical median of 21.93. Over the past decade, PCC Rokita's EBITDA Margin % has ranged from 14.17 to 32.51. According to the industry distribution chart, PCC Rokita ranks #526 out of 1578 companies in the Chemicals industry, placing it in the top 33.3%.
Is PCC Rokita's EBITDA Margin % too high?
PCC Rokita's current EBITDA Margin % of 10.76% is 51% below median its 10-year median of 21.93. Over the past 10 years, this metric has ranged from a low of 14.17 to a high of 32.51. The Chemicals industry median EBITDA Margin % is 9.64. PCC Rokita's value of 10.76% is 11.7% above this industry median. Based on the distribution chart, PCC Rokita ranks #526 out of 1578 companies in the Chemicals industry, which is above the industry midpoint. Overall, PCC Rokita has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PCC Rokita's EBITDA Margin % compare to DOW?
According to the Chemicals industry distribution chart, PCC Rokita ranks #526 out of 1578 companies for EBITDA Margin %. This puts PCC Rokita in the upper half of its industry. The industry median EBITDA Margin % is 9.64. PCC Rokita's value of 10.76% is 11.7% above this benchmark. Historically, PCC Rokita's own EBITDA Margin % has ranged from 14.17 to 32.51 over the past decade. While the company's 10-year median is 21.93 vs. the industry median of 9.64, PCC Rokita has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,578 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PCC Rokita's current EBITDA Margin % of 10.76% is 11.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PCC Rokita and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PCC Rokita's current EBITDA Margin % is 10.76%, which is 51% below median its own 10-year median of 21.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PCC Rokita stock overvalued right now?
Based on GuruFocus' analysis, PCC Rokita (WAR:PCR) is currently considered Fairly Valued. The stock's GF Value™ is zł66.24, compared to a current price of zł69.50 — trading 4.9% above its estimated fair value. The current EBITDA Margin % is 10.76%, which is 51% below median its 10-year median of 21.93 and 11.7% above the Chemicals industry median of 9.64. PCC Rokita's overall GF Score™ is 82/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For PCC Rokita (WAR:PCR), the current EBITDA Margin % is 10.76% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PCC Rokita (WAR:PCR) Overvalued in 2026?
Based on GuruFocus' analysis, PCC Rokita stock appears to be overvalued.
The current stock price of zł69.50 is trading 4.9% above its estimated GF Value™ of zł66.24.
GuruFocus considers PCC Rokita to be Fairly Valued.
Key valuation signals for WAR:PCR:
EBITDA Margin %: 10.76% (51% below median its 10-year median of 21.93)
GF Value™: zł66.24 vs. price of zł69.50 (4.9% above fair value)
Industry Position: 11.7% above the Chemicals median (#526 of 1578)
No single metric tells the full story. See the WAR:PCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PCC Rokita SA is engaged in manufacturing chemicals. Its products include Polyols, Chloralkali, Chlorobenzene, Phosphorus derivatives, and Naphthalene derivatives. It serves adhesives, agrochemicals, building and construction, case, detergents, fire prevention, food and fuel industry, furniture, I&I cleaning, lubricants and functional fluids, metallurgical, mining and drilling, oilfield, paints and coatings, personal care, pharmaceuticals, plastics, power, printing ink, pulp and paper, raw materials and intermediates, refrigeration and household appliances, sports and recreation, tanning and textile, transportation, and water and wastewater treatment industries.
82GF Score
Get the complete analysis for WAR:PCR
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:PCR has been successfully added to your 
